Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- Check6 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study content. This indicates that access to the record is blocked.SummaryDifference0.5%

- Check27 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, indicating restricted access. Added elements include the 403 header and a Home link, signaling a site-access issue rather than an update to the study information.SummaryDifference17%

- Check48 days agoChange DetectedThe page adds a new study ID entry '2018 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers. The page revision label is updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check62 days agoChange DetectedAdds IPD sharing policy details, including the plan to share individual participant data, access criteria, and time frames, along with related links and identifiers. This expansion provides information on how de-identified data may be requested and shared with qualified researchers.SummaryDifference88%

- Check69 days agoChange DetectedA new revision label, v3.6.5, was added and the previous label v3.6.4 was removed. This updates the page's revision metadata but does not change the study content or functionality.SummaryDifference0.0%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.